![RunTheList on Twitter: "So... why do these antibodies matter, clinically? 🩺 recognizing specific phenotypes associated with myositis-specific antibodies (MSAs) can help identify the particular IIM subtype and its various systemic manifestations More RunTheList on Twitter: "So... why do these antibodies matter, clinically? 🩺 recognizing specific phenotypes associated with myositis-specific antibodies (MSAs) can help identify the particular IIM subtype and its various systemic manifestations More](https://pbs.twimg.com/media/Ety3vzmWQBAErxl.jpg)
RunTheList on Twitter: "So... why do these antibodies matter, clinically? 🩺 recognizing specific phenotypes associated with myositis-specific antibodies (MSAs) can help identify the particular IIM subtype and its various systemic manifestations More
![A Clinically and Biologically Based Subclassification of the Idiopathic Inflammatory Myopathies Using Machine Learning - Eng - 2020 - ACR Open Rheumatology - Wiley Online Library A Clinically and Biologically Based Subclassification of the Idiopathic Inflammatory Myopathies Using Machine Learning - Eng - 2020 - ACR Open Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/244a8c37-5509-44e5-8c9d-ea2202e416d5/acr211115-fig-0004-m.jpg)
A Clinically and Biologically Based Subclassification of the Idiopathic Inflammatory Myopathies Using Machine Learning - Eng - 2020 - ACR Open Rheumatology - Wiley Online Library
![Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80% More in overlap Low in IBM Defined antibodies:50% - ppt download Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80% More in overlap Low in IBM Defined antibodies:50% - ppt download](https://images.slideplayer.com/15/4723201/slides/slide_3.jpg)
Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80% More in overlap Low in IBM Defined antibodies:50% - ppt download
![Amazon.com : CICA Peptide Anti Hair Loss, Derma Scalp Treatment, 1.69 fl oz (50 ml), Some By Mi : Beauty & Personal Care Amazon.com : CICA Peptide Anti Hair Loss, Derma Scalp Treatment, 1.69 fl oz (50 ml), Some By Mi : Beauty & Personal Care](https://m.media-amazon.com/images/I/71lI69RZGNS.jpg)
Amazon.com : CICA Peptide Anti Hair Loss, Derma Scalp Treatment, 1.69 fl oz (50 ml), Some By Mi : Beauty & Personal Care
![A Clinically and Biologically Based Subclassification of the Idiopathic Inflammatory Myopathies Using Machine Learning - Eng - 2020 - ACR Open Rheumatology - Wiley Online Library A Clinically and Biologically Based Subclassification of the Idiopathic Inflammatory Myopathies Using Machine Learning - Eng - 2020 - ACR Open Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3368df22-e9d6-4deb-a0a0-97991a83d8cd/acr211115-fig-0005-m.jpg)
A Clinically and Biologically Based Subclassification of the Idiopathic Inflammatory Myopathies Using Machine Learning - Eng - 2020 - ACR Open Rheumatology - Wiley Online Library
![Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d68ee9929e10967b7bbaaa1abccfde11475c6f2d/3-Table1-1.png)
Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar
![Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d68ee9929e10967b7bbaaa1abccfde11475c6f2d/6-Table2-1.png)
Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar
![John Libbey Eurotext - European Journal of Dermatology - Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis John Libbey Eurotext - European Journal of Dermatology - Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis](https://www.jle.com/e-docs/00/04/D5/15/jleejd3750gr1.jpg)